Glucagon-like peptide-1 (GLP-1) receptor agonists, originally developed for type 2 diabetes and obesity, have recently attracted interest as potential modulators of addictive behavior. This narrative review summarizes cu...
GLP-1 Receptor Agonists in Addiction Psychiatry—Neurobiological Rationale, Emerging Clinical Evidence, and Cautions for Practice: A Narrative Review
